Elisabetta Parisi

Elisabetta Parisi

Place and date of birth : Vibo Valentia (VV), (Italy), 26 november 1976

Address: 27, ugo bertossi street,00159 Rome (Italy)

e-mail: [mailto:parisielisabetta@libero.it]

[mailto:e.parisi@irst.emr.it]

PROFILE

I have a strong-willed, dynamic and enterprising personality . I enjoy working in groups and collaborate. Interested in new experience and professional looking for new challenges. My current interests are the study of head and neck cancers and lung cancers, in particular mesotheliomas.

EXPERIENCE

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), Meldola, Italy

From apr 2009

Currently employed as Radiation Oncologist Physician at IRCCS Istituto scientific romagnolo per lo Studio e la Cura dei Tumori

Involved in the clinical and research activities of a 1200 patient / year facility.

The main duties include:

• Development of outpatient cilinal activity
• Contouring
• Approved care plans
• Member of multidisciplinary teams of GIPO and HEAD and NECK cancer
• Manager of radiationtherapy department’s intranet and internet

Ospedale S. Giovanni Calibita, Fatebenefratelli (Rome) jan 2009-mar 200 Annual Fellowship A.Fa.R in RadiationTherapy Department : “Analisi delle potenzialità della metodica

radioterapia di ottimizzazione della dose IMRT (Intensity Modulated Radiotherapy) e nuove metodiche

di centratura (simulazione virtuale) ed Integrazione di Imaging (fusione di immagini TC/RM) nel

trattamento radioterapico della neoplasia prostatica”

Istituto di Ematologia, Policlinico “Umberto I” oct 2007 - mar 2009

Worked as frequent physician at the Radiotherapy Department

Casa di Cura Privata Nostra Signora della Mercede (Rome) feb 2007 - mar 2009

Worked in the radiotherapy department as Radiation Oncologist Physician

Casa di Cura San Francesco Caracciolo Hospice (Roma), agreement with the NHS jan 2008 – jul 2008

Worked in the oncological department and home care as palliative care physician

Medical Laboratory CGH, Rome, Italy jan 2006- feb2007

Worked as a phlebotomist

Istituto di Ematologia, Policlinico “Umberto I” sept 2005 - sept 2006

In training at the Radiotherapy Department

Instituti Fisioterapici Ospitalieri - Istituto Regina Elena, Rome, Italy jan 2004 – jun 2004

In training at the Medical Oncology Department A, Head of Department Prof. Cognetti.

Policlinico “Umberto I” mar 1999-aug 2003

In training at the Clinics of the Cancer Prevention and Senology, Department of S.S. Oncology, Head of Department. Prof. Frati.

EDUCATION

Radiation Oncologist degree 24/10/ 2007

Vote of 70/70 cum laude

Thesis: “Effetti tardivi del trattamento radio-chemioterapico nei pazienti pediatrici affetti da Linfoma di Hodgkin”,

i.e. “Late effects of radio-chemotherapy treatment in pediatric patients with Hodgkin's lymphoma.”

Universita` degli Studi di Roma “La Sapienza”, Rome, Italy

Registration to the “Order of Physicians and Dentists”” of Vibo Valentia Dec 2003

Pursue Medical Profession Jun 2003

Master Medicine degree 08/11/ 2002

Vote of 110/110 cum laude

Thesis: “Esame citologico della secrezione mammaria e prevenzione del carcinoma della mammella”,

i.e. “Cytological examination of mammary secretion and prevention of breast cancer”

Universita` degli Studi di Roma “La Sapienza”, Rome, Italy

High school Scientific degree 1995

Vote of sixty / sixtieths

“ Liceo Scientifico Statale Vibo Valentia”

SKILLS

Languages: Italian (Mother tongue), English (Proficient)

TPS: Ergo, Pinnacle³,Cadplan, Eclipse, TomoTherapy

EMR: Varis, Mosaiq.

PUBLICATIONS

1. D. Arpa, E. Parisi, A. Romeo, G. Ghigi, R. Bellia, B. Dipalma, E.M.L. Neri, S. Laganà, G. Pascale, S. Micheletti, F. Moretto, N. Riva, V. D'errico, A. Tesei, A. Sarnelli, N. Minguzzi, R. Polico. “ Hypofractionted stereotactic Image Guided Helical tomotherapy for the treatment od recurrent glioblastoma”. Int J Rad Onc Biol Phys, vol 93, Issue 3, Suppl,15Nov 2015
2. E. Parisi, A. Romeo, G. Ghigi, A. Delmonte, B. Dipalma, S. Micheletti, E. Neri, A. Sarnelli, C. Arienti, Polico R. “High-Dose Radiation Therapy for the Treatment of Pleural Mesothelioma After Pleurectomy/Decortication or Biopsy: Long-term Follow-up, Acute and Late Toxicity: Mesothelioma, Thymic Malignancies, and Other Thoracic Malignancies [http://www.sciencedirect.com/science/article/pii/S0360301614038772] ”. Int J Rad Onc Biol Phys, vol 90, Issue 5, Suppl, 15 Nov 2014.
3. E. Parisi, G. Genestreti, A. Romeo, M. Romagnoli, M. Burgio, G. Ghigi, D. Arpa, A. Sarnelli, A. Tesei, R. Polico. “ Accelerated hypofractionated radiation therapy plus chemotherapy for inoperabile locally advanced lung cancer: final results of long term follow up.” Int J Rad Onc Biol Phys, vol 90, Issue 1, Suppl, Nov 2014.
4. A. Romeo, E. Parisi, A. Passardi, S.R. Bellia, D. Arpa, G. Ghigi, E. Neri, A. Sarnelli, A. Tesei, B. Dipalma, R. Polico. “ Locoregional hypofractionated radio-chemotherapy for unresectable nonmetastatic pancreatic cancer.”. Int J Rad Onc Biol Phys, vol 90, Issue 1, Suppl, Nov 2014.
5. Ridolfi L., de Rosa F, Gentili G, Valmori L, Scarpi E, Parisi E, Romeo A, Guidoboni M.“Radiotherapy as an immunological booster in patients with metastatic melanoma or renal cell carcinoma treated with high-dose Interleukin-2: evaluation of biomarkers of immunologic and therapeutic response. [http://www.ncbi.nlm.nih.gov/pubmed/25245327] ” J Transl Med. 2014 Sep 23;12:262.
6. Tesei A, Sarnelli A, Arienti C, Menghi E, Medri L, Gabucci E, Pignatta S, Falconi M, Silvestrini R, Zoli W, d’Errico V, Romeo A, Parisi E, Polico R. “In vitro irradiation system for radiobiological experimets” Radiation Oncol 2013; 8:256 (Nov 2013).
7. Arienti C, Tesei A, Carloni S, Ulivi P, Romeo A, ghigi G, Menghi E, Sarnelli A, Parisi E, Silvestrini R, Zoli W. “ Slug silencing increase radiosensivity of melanoma cells in vitro” Cell oncol (Dodr) 2013; 36(2):131-9
8. A. Romeo, E. Parisi, A. Passardi, S. Bellia,D.Arpa, G. Ghigi, E. Neri, A. Sarnelli, A. Tesei, R. Polico. “ Hypofractionated chemoradiation therapy with gemcitabine plus oxaliplatin for unresectable nonmetastatic locally advanced pancreatic carcinoma.”Int J Rad Onc Biol Phys, vol 87, Issue23, Suppl,15Nov 2013.
9. E. Parisi, A. Sarnelli, M. Giannini, G. Ghigi, A. Romeo, S. Micheletti, E. Neri, A. D'Angelo, E. Menghi, R. Polico. “Accelerated Hypofractionated Radiation Therapy Using Helical Tomotherapy for the Treatment of Medically Inoperable Pleural Mesothelioma: IRST Preliminary Data [http://www.sciencedirect.com/science/article/pii/S0360301612024868] ”. Int J Rad Onc Biol Phys, vol 84, Issue 3, Suppl 1 Nov 2012
10. E. Parisi, A. Romeo, G. Ghigi, S. Bellia, M. Giannini, S.Micheletti,E. Neri, A. dAngelo, C. Fabbri, E. Menghi, A. Sarnelli, R.Polico "Accelerated hypofractionated radiotherapy in inoperable locally advanced lung cancer usingtomotherapy: our experience"Strahlenther Onkol 2011;187:680
11. E. Parisi, G. Ghigi, A. Romeo, S. Bellia, M. Giannini, S.Micheletti,E. Neri, A. dAngelo, C. Fabbri, E. Menghi, A. Sarnelli, R.Polico"Tomotherapy in the treatment of inoperable pleural mesothelioma" Strahlenther Onkol 2011;187:679
12. G. Ghigi, A. Sarnelli, E. Parisi, A. Romeo, S. Bellia, M.Giannini,S. Micheletti, E. Neri, A. dAngelo, C. Fabbri, E. Menghi, R.Polico"Tomotherapy and accelerated hypofractionated schedule for locally advanced lung cancer: clinical and radiobiological considerations based on a case report"Strahlenther Onkol 2011;187:701
13. A. Sarnelli, A. Romeo, E. Parisi, G. Ghigi, S. Bellia, M.Giannini,S. Micheletti, E. Neri, A. d Angelo, C. Fabbri1, E. Menghi, R.Polico "Tomo vs VMAT vs tangential fields to reduce cardiovascular complications in breast cancer therapy"Strahlenther Onkol 2011;187:688
14. Genestreti G., Piciucchi S., Romeo A, Parisi E., Monti M., Giovannini N., Poletti V., Matteucci F., Polico R. “Preliminary results of induction cisplatin/Docetaxel follone by short course thoracic radiotherapy and Cisplatin/docetaxel of consolidation in locally advanced non-small cell lung cancer (NSCLC): a prospective phase II trial.” (Journal of Thor Oncol 2011; 6 (6) suppl 2)
15. Genestreti G., Piciucchi S., Romeo A, Parisi E., Scarpi M., Moretti A., Matteucci F., Polico R. “Induction chemotherapy followed by imensional hypofractionated accelerated radiotherapy (3D-HAR) in locally advanced non small cell lung cancer(NSCLC): our experience” (Journal of Thor Oncol 2011; 6 (6) suppl 2)
16. Micheletti S, Giannini M, Bellia SR, Romeo A, Ghigi G, Parisi E, Ruggieri R, Naccarato S, d’Angelo A, Menghi E, Sarnelli A, Polico R. “New tendencies in rachis bone metastasis radiotherapy treatment” (I congresso SIO, Novembre 2010)
17. Giannini M, Bellia S.R, d’Angelo A, Ghigi G, Menghi E, Micheletti S, Naccarato S, Parisi E, Polico R, Romeo A, Ruggieri R, Sarnelli A. “ Clinical outcomes indicators in prostate carcinoma” ( Tumori suppl vol 8(1), November 2009).
18. G.Ghigi, S.R.Bellia, M.Giannini, S.Micheletti, E Parisi , A.Romeo, A. d’Angelo, E.Menghi, S.Naccarato, A.Sarnelli, R.Ruggieri and R.Polico, “Inter and Intra-fractional variations in patient setup treated with tomotherapy for lung cancer.”

    ( Tumori suppl vol 8(1), November 2009);

19. Ruggieri R, Naccarato S, d’Angelo A, Menghi E, Sarnelli A, Sceni G, Bellia SR, Ghigi G, Giannini M, Micheletti S, Parisi E, Romeo A, Polico R, “Modelli radiobiologici di TCP in Radioterapia.” Contributo AIFM 2009;
20. Naccarato S, d’Angelo A, Menghi E, Sarnelli A, Furini G, Zimbelli A, Bellia SR, Ghigi G, Giannini M, Parisi E, Micheletti S, Romeo A, Polico R, Ruggieri R, “Tomotherapy: caratterizzazione fisica dell’imaging MVCT.” Contributo AIFM 2009;
21. d’Angelo A, Menghi E, Naccarato S, Sarnelli A, Furini G, Zimbelli A, Bellia SR, Ghigi G, Giannini M, Micheletti S, Parisi E, Romeo A, Polico R, Ruggieri R, “L’esperienza I.R.S.T. nel ‘commissioning’ e nella validazione di un sistema per piani di trattamento Pinnacle3 ”; contributo AIFM 2009;
22. Musio D, Parisi E, Dionisi F, Parisi G, Caiazzo R, Bulzonetti N, Lichtner M, Raffetto N, Vullo V, Banelli E. “Irradiated fields spared by Stevens-Johnson syndrome in a patients undergoing radiotherapy for bone metastases” (Radiation Medicine vol 27(2), February 2009);
23. Comito T, Dionisi F, Parisi E, Monaco A, Parisi G, Bangrazi C, Musio D, Raffetto N.“Feasibility of the addition of weekly oxalyplatin to the standard neoadjuvant treatment of locally advanced rectal cancer” (Tumori suppl 6(1), November 2007);
24. Parisi E, Dionisi F, Comito T, Maglio R, D’Ignazio L, Grapulin L, Vitturini A, Banelli E. “Results of treatment with radiation therapy in MALT Lymphoma” (Tumori suppl 6(1), November 2007);
25. De Filippi I, Bressi C, Fabretti F, Madia M, Parisi E, Musio D, Vitturini A, Raffetto N, Banelli E. “Local control disease in elderly patients with squamous cell carcinoma of head and neck treated with radiotherapy alone instead of radiochemotherapy” (Tumori suppl. 5 (3), May-June 2006;
26. Donato V, Ciriello F, Musio D, Parisi E, Rollo A, Maglio R, Banelli V. “Organ preservation: bladder carcinoma” (Archivio italiano di Urologia e Andrologia 77(3), suppl 2, September 2005;
27. Rondinelli R, Ferrone L, Lembo R, Proietto M, Verì A, Madia M, Parisi E, Occhiato R, Frati L. “The cytology of nipple discharge and prevention of breast cancer” (Annals of Oncology 2002, suppl.3);
28. Lacava V, Ferrone L, Rondinelli R, Lembo R, Verì A, Parisi E, Palese A, Rocchi M, Salesi N, Masi MC, Masoni L. “Neoplasie del colon-retto: metodologie di prevenzione” (III Congresso Interregionale AIOM, 2001);
29. FerroneL, Lacava V, Lembo R, Masi MC, Rocchi M, Parisi E, Palese A, Verì A, Rondinelli R, Salesi N. “Early diagnosis in an integrated breast pathology unit” (3rd Milan Breast Cancer Conference 2001);
30. Lacava V, Salesi N, Ferrone L, Verì A, Lembo R, Masi MC, Rocchi M, Rondinelli R, Parisi E, Greco T, Balzani A, Clerico R, D’Innocenzi D, Bottoni U, Calmieri S. “Importanza di uno screening dermatologico nell’ambito di un programma di prevenzione oncologica generale” (Minerva Medica 2001 vol.92, num.2);
31. Salesi N, Lacava V, Ferrone L, Rondinelli R, Lembo R, Masi MC, Parisi E, Palese A, Verì A, Rocchi M. “Early diagnosis of prolactinomas: our experience” (Annals of Oncology 2001, vol. 12, suppl.4);
32. Ferrone L, Salesi N, Masi MC, Rondinelli R, Lembo R, Verì A, Parisi E, Palese A, Madia M, Rocchi M, Giudice E. “Correlation between osteoporosis and breast cancer” (Annals of Oncology 2001, vol. 12, suppl.4);
33. Frati L, Ferrone L, Lembo R, Masi MC, Parisi E, Palese A, Madia M, Rocchi M, Verì A, Masoni L, Salesi N, Rondinelli R, Lacava V. “Lesioni precancerose del grosso intestino nei pazienti anziani con familiarità per il cancro della mammella e del colon-retto” (Minerva Medica 2001; suppl.1, num.4);
34. Salesi N, Verì A, Ferrone L, Proietto M, Palese A, Salesi E, Madia M, Parisi E, Rondinelli R. “Il ruolo dello screening nel controllo dei tumori cutanei” (Tribuna Biologica e Medica, Anno 2001 vol.9, num.3-4);
35. Rondinelli R, Parisi E, Proietto M, Palese A, Madia M, Verì A, Ferrone L. “Il Fas e i meccanismi molecolari alla base del tumor counter-attack: possibile ruolo nella genesi del cancro della mammella e delle metastasi epatiche da cancro del colon retto” (Tribuna Biologica e Medica, Anno 2001 vol.9, num.3-4);
36. Rondinelli R, Ferrone L, Masi MC, Rocchi M, Perroni O, Parisi E, Palese A, Verì A, Salesi N, Lembo R. “Fobt e prevenzione delle neoplasie colon rettali” (Tumori Supplement 1 to vol.87, num.3, 2001);
37. Lacava V, Ferrone L, Lembo R, Rocchi M, Parisi E, Perroni O, Giudice E, Palese A, Verì A, Rondinelli R, Salesi N, Masi MC. “Un esempio di organizzazione di prevenzione secondaria” (Tumori Supplement 1 to vol.87, num.3, anno 2001);
38. Salesi N, Ferrone L, Lembo R, Rondinelli R, Rocchi M, Parisi E, Palese A, Verì A, Masi MC, Toscani M, Lacava V. “Il carcinoma baso cellulare: epidemiologia, aspetti genetici e clinici, trattamento, prevenzione” (Tribuna Biologica e Medica, Anno 2001 vol.9, num.1-2);
39. Lacava V, Ferrone L, Lembo R, Masi MC, Parisi E, Palese A, Di Fusco MT, Rocchi M, Rondinelli R, Salesi N, Masoni L. “Importanza del test per la ricerca del sangue occulto nelle feci in una popolazione a rischio afferente ad un centro di prevenzione oncologica” (Tribuna Biologica e Medica, Anno 2000 vol.8, num.1-2);

PRESENTATIONS

1. On September 29, 2009 on Single-issue meetings of the multidisciplinary thoracic department 2009, held in U.O.Chirurgia Toracica - Forlì , presented the report: “Attuali indicazioni alla radioterapia nella patologia toracica: Early stage non-small cell lung cancer”

2. On September 26, 2009 at the course on “Diagnosi e terapia dei carcinomi del distretto testa-collo: approccio multidisciplinare”, held in Forlì, presented the report: “La radioterapia nel trattamento dei tumori testa-collo”
3. On June 22, 2010 at 23th National Annual Meeting of young Surgeons (SPIGC), held in Camera di Commercio-Forlì, presented the report : “Indicazioni della radioterapianei carcinomi in stadio precoce del distretto testa-collo”.
4. On November 20, 2010 at the meeting ofLa Tomoterapia in Italia: esperienze a confrontopresented the report :

   “L’esperienza di Meldola: ipofrazionamento” (Forte di Bard, Aosta, 20/11/2010)

5. On June 14, 2011 at the meeting “Progressi in radioterapia oncologica” presented the report “La radioterapia stereotassica del polmone” (Verona, Azienda ospedaliera Universitaria Integrata-Centro Marani)
6. On June 9, 2011 Salotti in Rosa- Incontro con le pazienti, presented the report:” Gli effetti collaterali del trattamento radiante” (Cesena, Ospedale Bufalini)
7. On June 24, 2011IUser Meeting nazionale (Tomotherapy), presented the report “Ipofrazionamento accellerato: problematiche. Protocolli Clinici” (San Servolo, Venezia)
8. On September 16,2011 at the meeting of International Tomotherapy Conference, held in Heidelberg, Germany, presented the report “Accelerated hypofractionated radiotherapy in IIIB lung cancer using Tomotherapy: our experience”
9. On September 16,2011 at the meeting of International Tomotherapy Conference, held in Heidelberg, Germany, presented the report “Hypofractionated radiotherapy using tomotherapy in the treatment of inoperable pleural mesothelioma”
10. On May 11,2012 at the meeting of ESTRO 31, held in Barcellona, Spain, presented the selected report for “Young Scientists session”“Pallitaive radiotherapy for inoperable pleural mesothelioma using Tomotherapy”.
11. On May 14, 2012 at the meeting of News in Medical Physic, held in San Giovanni Rotondo, presented the report “Clinical Indications to Tomotherapy treatments: Meldola’s experience”

12. On May 24, 2012 at the meeting of FONICAP forPleural Mesothelioma: VI course of news in multidisciplinary approach, presented the report “ Radiotherapy: Tradition and Innovation”
13. On October 31,2012 at the ASTRO 54^th edition, held in Boston USA, presented he report: “Accelerated hypofractionated radiotherapy using tomotherapy plus chemotherapyfor inoperable locally advanced lung cancer: preliminary results from a prospective phase II trial.”

14. On October ,2014 at the ASTRO 56^th edition, held in S. Francisco USA, presented he report: “Accelerated hypofractionated radiotherapy using tomotherapy plus chemotherapyfor inoperable locally advanced lung cancer: final results with a long term follow up.”

15. On May ,2014 at the 3^th International Conference Translational Research in Oncology, held in IRST Meldola, presented the report: “Radiotherapy”

16. On September,2014 at the meeting “La patologia oncologica della laringe”, held inMilano Marittima, presentedthe report: “La radioterapia nel trattamento del tumore della laringe”

17. On June ,201 at the meeting “Update nel management diagnostico e terapeutico del tumore della tiroide ”, held in IRST Meldola, presentedthe report: “La radioterapia nel trattamento del tumore della tiroide”